Natacha Benrimoh

Statistics

Publications

Citations

183

H-Index

Active since

2015

Affiliations

Exelixis (United States)(Current)

Celerion (Canada)

Celerion (United States)

Natacha Benrimoh is an author at Exelixis (United States) specializing in clinical pharmacology, pharmacology, and tyrosine kinase inhibitor pharmacokinetics.

Publications per year

2015–2016

Publications

Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK

Linh T. Nguyen, Jaymes Holland, Dale Miles et al. · The Journal of Clinical Pharmacology · 2015 · 75 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +17

Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib

Linh T. Nguyen, Jaymes Holland, David A. Ramies et al. · The Journal of Clinical Pharmacology · 2016 · 55 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Pharmacokinetics of cabozantinib tablet and capsule formulations in healthy adults

Linh Thuy Nguyen, Natacha Benrimoh, Yuli Xie et al. · Anti-Cancer Drugs · 2016 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

1–3 of 3